scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/S00423-009-0546-0 |
P8608 | Fatcat ID | release_72msdnibjrgprg5zcqaoyn62qa |
P698 | PubMed publication ID | 19644703 |
P2093 | author name string | Stephan Vogt | |
Andreas Nussler | |||
Sabrina Ehnert | |||
Ulrich Stöckle | |||
Andreas Schmitt | |||
Matthias Glanemann | |||
Natascha C Nussler | |||
Naama Shanny | |||
P2860 | cites work | The renal papilla is a niche for adult kidney stem cells | Q24562153 |
Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
Generation of germline-competent induced pluripotent stem cells | Q28131699 | ||
Hepatic differentiation of murine embryonic stem cells | Q28210211 | ||
Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction | Q28248284 | ||
Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model. | Q54576023 | ||
Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. | Q55043529 | ||
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts | Q59064540 | ||
The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion | Q60249427 | ||
Adult-Derived Human Liver Mesenchymal-Like Cells as a Potential Progenitor Reservoir of Hepatocytes? | Q62513820 | ||
Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors | Q63384348 | ||
Hepatocyte transplantation: New possibilities for therapy | Q64355638 | ||
Hepatocyte transplantation in man | Q67966773 | ||
Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture | Q72731478 | ||
Route of hepatocyte delivery affects hepatocyte engraftment in the spleen | Q73939264 | ||
Bone marrow transplantation for the heart: fact or fiction? | Q78761485 | ||
Autologous bone-marrow stem-cell transplantation for myocardial regeneration | Q78761519 | ||
Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro | Q79894622 | ||
Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes | Q80538968 | ||
Study on the colonoscopic features of GVHD enteritis that developed after hematopoietic stem cell transplantation | Q80674953 | ||
Autologous osteochondral grafting--technique and long-term results | Q80804662 | ||
Hepatocyte transplantation for inherited factor VII deficiency | Q81186735 | ||
Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives | Q81443592 | ||
Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation | Q81517600 | ||
Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells | Q81537344 | ||
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients | Q81676895 | ||
Transplantation of monocyte-derived hepatocyte-like cells (NeoHeps) improves survival in a model of acute liver failure | Q83078384 | ||
Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. | Q51010442 | ||
Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty. | Q53581144 | ||
Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells. | Q54505891 | ||
Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation | Q28270302 | ||
Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages | Q28567614 | ||
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state | Q29614212 | ||
Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. | Q30319281 | ||
Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. | Q30319983 | ||
Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. | Q33230391 | ||
Full-thickness tissue engineered skin constructed with autogenic bone marrow mesenchymal stem cells | Q33291791 | ||
Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo | Q33299826 | ||
Hepatocyte transplantation for the treatment of human disease | Q33647660 | ||
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. | Q34010010 | ||
Emerging therapies in hepatology: liver-directed gene transfer and hepatocyte transplantation | Q34022216 | ||
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone | Q34066339 | ||
Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats | Q34105205 | ||
Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation | Q34315088 | ||
Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction | Q34339063 | ||
Stem cell approaches for the treatment of renal failure | Q34444175 | ||
Generation of human induced pluripotent stem cells from dermal fibroblasts | Q34588555 | ||
Marrow stimulation techniques | Q34757203 | ||
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors | Q34791180 | ||
Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta | Q34802739 | ||
Human embryonic stem cell technologies and drug discovery | Q34960815 | ||
A new cell therapy using bone marrow cells to repair damaged liver | Q35062130 | ||
Bone marrow stem cells contribute to repair of the ischemically injured renal tubule | Q35108468 | ||
Hepatic tissue engineering for adjunct and temporary liver support: critical technologies | Q35924474 | ||
In search of adult renal stem cells. | Q35985545 | ||
Retroviral gene therapy: safety issues and possible solutions | Q36002660 | ||
Future strategies in the treatment of acute renal failure: growth factors, stem cells, and other novel therapies | Q36084576 | ||
Adult stem cells in renal injury and repair | Q36164072 | ||
Cardiac stem cells and mechanisms of myocardial regeneration | Q36267790 | ||
Myocardial aging--a stem cell problem | Q36291645 | ||
Cardiomyocytes derived from stem cells | Q36309565 | ||
Cardiac regeneration: repopulating the heart | Q36387864 | ||
Stem cells in kidney regeneration following acute renal injury | Q36426355 | ||
Stem cells and kidney injury | Q36446057 | ||
Present status and perspectives of cell-based therapies for liver diseases | Q36490659 | ||
Biomimetic materials for tissue engineering | Q36502929 | ||
Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. | Q36572629 | ||
Human embryonic stem cells: current technologies and emerging industrial applications. | Q36906133 | ||
The application of human embryonic stem cell technologies to drug discovery | Q36934795 | ||
Reprogramming of murine and human somatic cells using a single polycistronic vector | Q37068363 | ||
Stem-cell therapy for cardiac disease | Q37089732 | ||
Mesenchymal stem cells in cancer | Q37169180 | ||
Improving safety of gene therapy | Q37239524 | ||
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. | Q39394474 | ||
Intrasplenic or subperitoneal hepatocyte transplantation to increase survival after surgically induced hepatic failure? | Q40077761 | ||
Cell-mediated rejection results in allograft loss after liver cell transplantation | Q40099658 | ||
In vivo analysis of retroviral gene transfer to chondrocytes within collagen scaffolds for the treatment of osteochondral defects. | Q40107347 | ||
Cell behaviour on phospholipids-coated surfaces. | Q40124405 | ||
Modified keratin sponge: binding of bone morphogenetic protein-2 and osteoblast differentiation | Q40190372 | ||
A novel method of cryopreservation of rat and human hepatocytes by using encapsulation technique and possible use for cell transplantation | Q40358910 | ||
Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up | Q40562437 | ||
Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation | Q40611732 | ||
A reversibly immortalized human hepatocyte cell line as a source of hepatocyte-based biological support | Q40652505 | ||
Differentiated properties of hepatocytes induced from pancreatic cells | Q40708277 | ||
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. | Q40724468 | ||
Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines | Q40783492 | ||
Molecular basis of transdifferentiation of pancreas to liver | Q40833571 | ||
Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes | Q40834144 | ||
The clinical use of combined xenografts of bone and autologous red marrow. A preliminary report | Q40858977 | ||
Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural | Q42026710 | ||
Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism | Q42437508 | ||
Surface modification of interconnected porous scaffolds | Q43627233 | ||
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. | Q43878276 | ||
Percutaneous bone marrow grafting for the treatment of tibial non-union | Q43920295 | ||
Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy | Q44313167 | ||
Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells | Q44319078 | ||
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction | Q44392643 | ||
Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure | Q45103100 | ||
Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction. | Q45181821 | ||
Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. | Q45463789 | ||
Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion | Q45868131 | ||
Differentiation of monkey embryonic stem cells into hepatocytes and mRNA expression of cytochrome p450 enzymes responsible for drug metabolism: comparison of embryoid body formation conditions and matrices | Q46066514 | ||
One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects | Q46084227 | ||
Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. | Q46119541 | ||
Transplantation of engineered bone tissue using a rotary three-dimensional culture system | Q46279723 | ||
Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. | Q46478179 | ||
Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. | Q46479560 | ||
Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells | Q46531971 | ||
Use of the middle colic vein for liver cell transplantation in infants and small children | Q46539198 | ||
Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats | Q46937050 | ||
Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure | Q47302183 | ||
FGF-2 enhances vascularization for adipose tissue engineering | Q47836885 | ||
Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke | Q48262046 | ||
MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. | Q50481862 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | regenerative medicine | Q1061415 |
P304 | page(s) | 985-997 | |
P577 | publication date | 2009-07-31 | |
P1433 | published in | Langenbeck's Archives of Surgery | Q635673 |
P1476 | title | The possible use of stem cells in regenerative medicine: dream or reality? | |
P478 | volume | 394 |
Q38332493 | Adult human neural stem cell therapeutics: Current developmental status and prospect |
Q42542660 | Application of stem cells in orthopedics |
Q45812153 | Autologous serum improves yield and metabolic capacity of monocyte-derived hepatocyte-like cells: possible implication for cell transplantation |
Q40674950 | Blastema cells derived from New Zealand white rabbit's pinna carry stemness properties as shown by differentiation into insulin producing, neural, and osteogenic lineages representing three embryonic germ layers |
Q35203209 | Calcium alginate gels as stem cell matrix-making paracrine stem cell activity available for enhanced healing after surgery |
Q53155879 | Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues. |
Q57171240 | Evaluation of different commercial hyaluronic acids as a vehicle for injection of human adipose-derived mesenchymal stem cells |
Q41040478 | Fueling Hope: Stem Cells in Social Media |
Q38285672 | Growth factor delivery vehicles for tendon injuries: Mesenchymal stem cells and Platelet Rich Plasma. |
Q37845721 | Hematopoietic stem cell homing to injured tissues. |
Q38205960 | Hepatic progenitor cells in liver regeneration: current advances and clinical perspectives |
Q42081354 | Mathematical model of stem cell differentiation and tissue regeneration with stochastic noise |
Q37976114 | Mesenchymal stromal cells for tissue-engineered tissue and organ replacements |
Q46964474 | Nanotubes impregnated human olfactory bulb neural stem cells promote neuronal differentiation in Trimethyltin-induced neurodegeneration rat model. |
Q41320509 | Rapid Rapamycin-Only Induced Osteogenic Differentiation of Blood-Derived Stem Cells and Their Adhesion to Natural and Artificial Scaffolds. |
Q26781878 | Recent biological trends in management of fracture non-union |
Q37173495 | Role of Cartilage Forming Cells in Regenerative Medicine for Cartilage Repair. |
Q26740531 | Stem cell procedures in arthroscopic surgery |
Q37818596 | Stem cells for the treatment of neurodegenerative diseases. |
Q37890946 | Therapeutic potential of stem cell in liver regeneration |
Q50269152 | Ultrastructural analysis of human bone marrow mesenchymal stem cells during in vitro osteogenesis and chondrogenesis |
Search more.